Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

M Vallet-Regí, F Schüth, D Lozano, M Colilla… - Chemical Society …, 2022 - pubs.rsc.org
The present review details a chronological description of the events that took place during
the development of mesoporous materials, their different synthetic routes and their use as …

Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches

TB Emran, A Shahriar, AR Mahmud, T Rahman… - Frontiers in …, 2022 - frontiersin.org
Cancer is one of the leading causes of death worldwide. Several treatments are available for
cancer treatment, but many treatment methods are ineffective against multidrug-resistant …

Exosome-mediated delivery of Cas9 ribonucleoprotein complexes for tissue-specific gene therapy of liver diseases

T Wan, J Zhong, Q Pan, T Zhou, Y Ping, X Liu - Science advances, 2022 - science.org
CRISPR-Cas9 gene editing has emerged as a powerful therapeutic technology, but the lack
of safe and efficient in vivo delivery systems, especially for tissue-specific vectors, limits its …

CRISPR-based therapeutic genome editing: strategies and in vivo delivery by AAV vectors

D Wang, F Zhang, G Gao - Cell, 2020 - cell.com
The development of clustered regularly interspaced short-palindromic repeat (CRISPR)-
based biotechnologies has revolutionized the life sciences and introduced new therapeutic …

Spatiotemporal control of CRISPR/Cas9 gene editing

C Zhuo, J Zhang, JH Lee, J Jiao, D Cheng… - … and Targeted Therapy, 2021 - nature.com
The clustered regularly interspaced short palindromic repeats (CRISPR)/associated protein
9 (CRISPR/Cas9) gene editing technology, as a revolutionary breakthrough in genetic …

A proton‐activatable DNA‐based nanosystem enables co‐delivery of CRISPR/Cas9 and dnazyme for combined gene therapy

F Li, N Song, Y Dong, S Li, L Li, Y Liu… - Angewandte Chemie …, 2022 - Wiley Online Library
CRISPR/Cas9 is emerging as a platform for gene therapeutics, and the treatment efficiency
is expected to be enhanced by combination with other therapeutic agents. Herein, we report …

Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects

S Deng, X Li, S Liu, J Chen, M Li, SY Chew… - Science …, 2020 - science.org
Controlled release of CRISPR-Cas9 ribonucleoprotein (RNP) and codelivery with other
drugs remain a challenge. We demonstrate controlled release of CRISPR-Cas9 RNP and …

Rational design of poly (disulfide) s as a universal platform for delivery of CRISPR-Cas9 machineries toward therapeutic genome editing

J Guo, T Wan, B Li, Q Pan, H Xin, Y Qiu… - ACS Central …, 2021 - ACS Publications
We synthesized a series of poly (disulfide) s by ring-opening polymerization and
demonstrated that the copolymerization of monomer 1 containing diethylenetriamine …

Development of CRISPR/Cas delivery systems for in vivo precision genome editing

Y Chen, Y Ping - Accounts of Chemical Research, 2023 - ACS Publications
Conspectus Clustered, regularly interspaced, short palindromic repeat (CRISPR)/associated
protein 9 (CRISPR/Cas9) is emerging as a powerful genome-editing tool, enabling precise …

Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy

X Song, C Liu, N Wang, H Huang, S He, C Gong… - Advanced drug delivery …, 2021 - Elsevier
The clustered, regularly interspaced, short palindromic repeats (CRISPR)/CRISPR-
associated protein (Cas) systems are efficient and versatile gene editing tools, which offer …